Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Pollack

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Oncoimmunology|June 22, 2012
EGFR inhibitors, MHC expression and immune responses : Can EGFR inhibitors be used as immune response modifiers?Brian P Pollack
JAAD International|March 4, 2022
Cutaneous findings in myotonic dystrophyHa Eun Kong, Brian P Pollack
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2011
Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genesBrian P Pollack, Bishu Sapkota, Todd V Cartee
Experimental Dermatology|December 17, 2009
Activating transcription factor 3 (ATF3) expression is increased in erythema multiforme and is regulated by IFN-gamma in human keratinocytesBrian P Pollack, Bishu Sapkota, Paul L Haun
Oncoimmunology|March 14, 2013
Vemurafenib enhances MHC induction in BRAF<sup>V600E</sup> homozygous melanoma cellsBishu Sapkota, Charles E Hill, Brian P Pollack
Photochemistry and Photobiology|December 17, 2008
Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylationBrian P Pollack, Bishu Sapkota, Jeremy M Boss
Journal of the American Academy of Dermatology|June 7, 2021
Characteristics of the dermatologic cases on a popular crowdsourcing platformMyles R McCrary, Anika Wu, Brian P Pollack
Journal of the American Academy of Dermatology|January 10, 2021
Cannabinoids in dermatologic surgeryHa Eun Kong, Brian P Pollack, Travis W Blalock
Archives of Dermatology|December 21, 2006
Pustule-studded plaques after abrasion injuryKristin H Magee, Brian P Pollack, Gregory J Raugi
American Journal of Clinical Oncology|May 8, 2013
Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanomaDerick Okwan-Duodu, Brian P Pollack, David Lawson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Oncoimmunology|June 22, 2012
EGFR inhibitors, MHC expression and immune responses : Can EGFR inhibitors be used as immune response modifiers?Brian P Pollack
JAAD International|March 4, 2022
Cutaneous findings in myotonic dystrophyHa Eun Kong, Brian P Pollack
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2011
Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genesBrian P Pollack, Bishu Sapkota, Todd V Cartee
Experimental Dermatology|December 17, 2009
Activating transcription factor 3 (ATF3) expression is increased in erythema multiforme and is regulated by IFN-gamma in human keratinocytesBrian P Pollack, Bishu Sapkota, Paul L Haun
Oncoimmunology|March 14, 2013
Vemurafenib enhances MHC induction in BRAF<sup>V600E</sup> homozygous melanoma cellsBishu Sapkota, Charles E Hill, Brian P Pollack
Photochemistry and Photobiology|December 17, 2008
Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylationBrian P Pollack, Bishu Sapkota, Jeremy M Boss
Journal of the American Academy of Dermatology|June 7, 2021
Characteristics of the dermatologic cases on a popular crowdsourcing platformMyles R McCrary, Anika Wu, Brian P Pollack
Journal of the American Academy of Dermatology|January 10, 2021
Cannabinoids in dermatologic surgeryHa Eun Kong, Brian P Pollack, Travis W Blalock
Archives of Dermatology|December 21, 2006
Pustule-studded plaques after abrasion injuryKristin H Magee, Brian P Pollack, Gregory J Raugi
American Journal of Clinical Oncology|May 8, 2013
Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanomaDerick Okwan-Duodu, Brian P Pollack, David Lawson, et al.
Pageof 4